InvestorsHub Logo
Followers 79
Posts 24502
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Thursday, 05/23/2019 7:51:01 AM

Thursday, May 23, 2019 7:51:01 AM

Post# of 27408
NVCN - .4714 Pre-market now at .9016/.9077

Neovasc Announces Positive Two-Year Follow-up Safety and Efficacy Data for the Neovasc Reducer™ in a Peer Reviewed Article in the International Journal of Cardiology

https://www.tradescores.com/StockReport/nvcn

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.